Pakistani researchers identify metformin as promising future therapy for Oral Submucous Fibrosis

KARACHI: Researchers from Ziauddin University have identified metformin, one of the world's most widely prescribed diabetes medications, as a promising future therapeutic candidate for Oral Submucous Fibrosis (OSF) after publishing a comprehensive systematic review in one of the world's leading pharmacology journals.